Trump’s tariff gambit alarms voters and allies over Canada and generics

The White House is threatening targeted tariffs on Canada (potentially 50% on some goods) and on certain generic drugs (up to 100%), part of a broader effort to pressure trade talks and reshoring manufacturing. Officials argue the measures are narrow and will be delayed, with carve-outs intended to blunt consumer impact, but Republicans fear the moves could raise prices and complicate affordability messaging before the midterms. Canada is pressing for renewed talks and warns the move could damage the American brand in swing states, while trade experts say the strategy could backfire if consumers feel higher costs even with exemptions. The plan fits into a larger push that could eventually affect dozens of countries and a broader toolkit following recent rulings that limited prior trade powers.